Cargando…
Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine
Since the outbreak of COVID-19, a variety of vaccine platforms have been developed. Amongst these, inactivated vaccines have been authorized for emergency use or conditional marketing in many countries. To further enhance the protective immune responses in populations that have completed vaccination...
Autores principales: | Zhang, Jialu, He, Qian, An, Chaoqiang, Mao, Qunying, Gao, Fan, Bian, Lianlian, Wu, Xing, Wang, Qian, Liu, Pei, Song, Lifang, Huo, Yaqian, Liu, Siyuan, Yan, Xujia, Yang, Jinghuan, Cui, Bopei, Li, Changgui, Wang, Junzhi, Liang, Zhenglun, Xu, Miao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381941/ https://www.ncbi.nlm.nih.gov/pubmed/34278956 http://dx.doi.org/10.1080/22221751.2021.1957401 |
Ejemplares similares
-
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
por: He, Qian, et al.
Publicado: (2021) -
Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques
por: He, Qian, et al.
Publicado: (2022) -
Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine
por: Gao, Fan, et al.
Publicado: (2022) -
Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates
por: He, Qian, et al.
Publicado: (2022) -
Mixed formulation of mRNA and protein‐based COVID‐19 vaccines triggered superior neutralizing antibody responses
por: Zhang, Jialu, et al.
Publicado: (2022)